Medtech MVP

The promise of digital surgery is an insight driven intra-operative experience that drives a higher quality of care. To achieve this, the MedTech industry has the enormous task of developing devices that can inform surgeons when they need it most. This panel will explore data in healthcare not as an asset to be solely owned but as a product and the challenges and opportunities in front of us to unlocking this product’s potential.  

In today's evolving healthcare industry, successful medical device companies must establish contracts with a range of account types to effectively provide patient care. To ensure access to diverse patient populations, it is essential to have agreements with IDNs, GPOs, and HCP accounts. However, managing these contracts can become inefficient and time-consuming as businesses expand. This session aims to introduce a solution that enables visibility into contract conditions and commitments, leading to improved contract performance and commercial success. 

Bonus: Create effective HCP and HCO target lists using claims data to help prioritize and segment accounts. 

Medical technology products add immense value to the healthcare system in a myriad of ways. The benefits provided by medical technologies can be categorized into two major groups - those that provide “direct benefit” (e.g., devices that directly influence clinical outcomes) and those that provide “enabling benefit” (e.g., devices that facilitate improved surgical procedures, monitor patients remotely, or diagnose conditions). This panel will discuss how market development challenges and barriers differ between these two categories and provide some key lessons learned directly from company leaders in this space.

NASA defines the “Goldilocks zone” as the habitable zone around a star where liquid water can exist on the surface of surrounding planets. Like the third of the three bowls of porridge in the tale of Goldilocks and the Three Bears, this is the ”sweet spot” where it is neither too hot nor too cold, but just right for life to exist. This breakout discussion will apply the “Goldilocks zone” concept to buyers. Savvy fiduciaries strike a delicate balance during diligence to make deals that fall within a regulatory Goldilocks zone. Buyers avoid deals that are too cold, e.g., a company that lacks necessary regulatory and compliance controls. Likewise, they avoid deals that are too hot, e.g., a company that has the necessary regulatory and compliance controls in place but does not comply with them in practice. A distinguished panel will pull back the curtain on the due diligence process and supply helpful insights on how to make sure your next deal is “just right” from a regulatory diligence perspective.